Found: 19
Select item for more details and to access through your institution.
Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2022, v. 8, n. 2, p. 1, doi. 10.1177/20552173221105642
- By:
- Publication type:
- Article
C-Peptide and Its C-Terminal Fragments Improve Erythrocyte Deformability in Type 1 Diabetes Patients.
- Published in:
- Experimental Diabetes Research, 2009, p. 1, doi. 10.1155/2008/730594
- By:
- Publication type:
- Article
C-Peptide and Its C-Terminal Fragments Improve Erythrocyte Deformability in Type 1 Diabetes Patients.
- Published in:
- Experimental Diabetes Research, 2008, p. 1, doi. 10.1155/2008/730594
- By:
- Publication type:
- Article
Erratum to: Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration.
- Published in:
- 2017
- By:
- Publication type:
- Erratum
Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Efficacy and safety of empagliflozin in patients with type 2 diabetes from Asian countries: pooled data from four phase III trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 10, p. 1045, doi. 10.1111/dom.12699
- By:
- Publication type:
- Article
Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trial.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 10, p. 1526, doi. 10.1177/13524585221076717
- By:
- Publication type:
- Article
Spatio-Temporal Denoising for Depth Map Sequences.
- Published in:
- International Journal of Multimedia Data Engineering & Management, 2016, v. 7, n. 2, p. 21, doi. 10.4018/IJMDEM.2016040102
- By:
- Publication type:
- Article
Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study.
- Published in:
- Cardiovascular Diabetology, 2015, v. 14, n. 1, p. 1, doi. 10.1186/s12933-014-0169-9
- By:
- Publication type:
- Article
Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4- week study.
- Published in:
- Cardiovascular Diabetology, 2015, v. 14, n. 1, p. 85, doi. 10.1186/s12933-014-0169-9
- By:
- Publication type:
- Article
Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based Survey.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A Physician-Completed Digital Tool for Evaluating Disease Progression (Multiple Sclerosis Progression Discussion Tool): Validation Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Siponimod vs placebo in active secondary progressive multiple sclerosis: a post hoc analysis from the phase 3 EXPAND study.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 9, p. 5093, doi. 10.1007/s00415-022-11166-z
- By:
- Publication type:
- Article
Real-World Findings of Usability and Usefulness of Multiple Sclerosis Progression Discussion Tool: A Physician-Completed Digital Tool to Evaluate Early Signs of Disease Progression.
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 86
- By:
- Publication type:
- Article
Treatment satisfaction in type 2 diabetes patients taking empagliflozin compared with patients taking glimepiride.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Energy Balance After Sodium-Glucose Cotransporter 2 Inhibition.
- Published in:
- Diabetes Care, 2015, v. 38, n. 9, p. 1730, doi. 10.2337/dc15-0355
- By:
- Publication type:
- Article
Long-term safety and efficacy of empagliflozin, sitagliptin, and metformin: an active-controlled, parallel-group, randomized, 78-week open-label extension study in patients with type 2 diabetes.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Long-Term Safety and Efficacy of Empagliflozin, Sitagliptin, and Metformin.
- Published in:
- Diabetes Care, 2013, v. 36, n. 12, p. 4015, doi. 10.2337/dc13-0663
- By:
- Publication type:
- Article
Improvement of long-term risks of cardiovascular events associated with community-based disease management in Chinese patients of the Xinjiang autonomous region of China.
- Published in:
- 2020
- By:
- Publication type:
- journal article